Final Facilitator Guide - EngenderHealth

More documents

Recommendations

Info

Round IV NGO consortium: Indian Network for People Living with HIV/AIDS (INP+),Population Foundation of India (PFI), Confederation of Indian Industry (CII) andFreedom Foundation for their assistance in content development and pre-testingof the manual. Our special thanks to all the members of the State and DistrictLevel Networks of people living with HIV of INP+ from Maharashtra, Tamil Nadu,Andhra Pradesh, Karnataka, Nagaland and Manipur, for participating in the contentdevelopment, pilot testing of the manual and master peer educators training andfor providing valuable feedback.We thank the National AIDS Control Organization (NACO), World HealthOrganization (WHO) India office, Centres for Disease Control (CDC), India office,International Training and Education Centre on HIV (ITECH), India and the NGOConsortium partners for being an active part of the Technical Advisory Group forthe curriculum development and for critically reviewing the curriculum.A number of <strong>EngenderHealth</strong> Society staff and consultants have contributed tothe research, concept, writing, development, translation and production of thiscurriculum. We appreciate their substantial contribution and special thanks toDr. Vijayabhaskar Reddy Kandula, Geetha Venugopal, Vaibhavi Bhalekar,Chandramouli Peyyala, Dr. Sethuramashankaran, Thepuphi Kapuh, Meenu Ratnaniand Shishir Seth for their contribution to this manual. We are grateful to Dr. JyotiMehra and Susmita Das for providing overall guidance and support throughoutthe process. We thank Dr. Jyoti Vajpayee, Country Director for her leadershipand guidance in this endeavour.We are thankful to the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)Round IV Access to Care and Treatment (ACT) project for providing financial supportto this pioneering initiative.For more information, contact:<strong>EngenderHealth</strong> Society, F-6/8B, Poorvi Marg,Vasant Vihar, New Delhi-110057,Tel.: +91–11–26147123 / 24 / 25.iv
ABBREVIATIONSARTCD4GFATMIVDUMSMNNRTINRTIPLHAPPTCTSTITBAntiretroviral therapyA type of white blood cell used to monitor HIV disease stateGlobal Fund to Fight AIDS, Tuberculosis, and MalariaIntravenous drug userMen having sex with menNon-nucleoside reverse transcriptase inhibitorNucleoside reverse transcriptase inhibitorPeople Living with HIV/AIDSPrevention of parent-to-child transmissionSexually transmitted infectionTuberculosisv
Page 1 and 2: Adherence to Treatment for HIVA Tra
Page 3 and 4: © 2006 EngenderHealth Society.F-6/
Page 5 and 6: TABLE OF CONTENTSPREFACEACKNOWLEDGE
Page 7 and 8: PREFACEWith funding from the Global
Page 9: ACKNOWLEDGEMENTSWe acknowledge with
Page 13 and 14: The Facilitator Guide consists of:
Page 15 and 16: How to use the facilitator guideThe
Page 17 and 18: This symbol indicatesthe questions
Page 19 and 20: 8This box should becut and pasteona
Page 21: This symbolindicates the triggerque
Page 24 and 25: 1SECTION 1Section 1INTRODUCTIONS AN
Page 28 and 29: Section 1Then read out this definit
Page 32 and 33: Section 1Summarize the results as f
Page 34 and 35: Section 22. During the discussion,
Page 36 and 37: Section 2Where does HIV come from?N
Page 38 and 39: 1SECTION 2Section 2HIV AND ANTIRETR
Page 40 and 41: Section 210. You cannot contract HI
Page 42 and 43: Section 2The list may include the f
Page 44 and 45: Section 2• If you do not take you
Page 46 and 47: Section 2Steps1. Ask the group if t
Page 48: Section 26. Tell the group that to
Page 52 and 53: 2SECTION 3Section 3RESISTANCE AND A
Page 54 and 55: 2SECTION 3Section 3RESISTANCE AND A
Page 56 and 57: Section 3most appropriate. Creativi
Page 58 and 59: Section 34. Provide 15 minutes for
Page 60 and 61:
Section 3Case Study #2Devi, a perso
Page 62 and 63:
2SECTION 3Section 3RESISTANCE AND A
Page 64 and 65:
Section 37. Finish the session by r
Page 66 and 67:
Section 32. Ask for a volunteer to
Page 68 and 69:
2SECTION 4Section 4PREVENTION PRACT
Page 70 and 71:
Section 4Reasons include• Parents
Page 72:
Section 4Case Study #2Usha, A women
Page 76 and 77:
3SECTION 4Section 4POSITIVE PREVENT
Page 78 and 79:
Section 45. After all four role pla
Page 80 and 81:
Section 4Group ThreeReinfectionYou
Page 82 and 83:
Page 84 and 85:
Section 4pouch is called the inner
Page 86 and 87:
Section 4Choose four or five that y
Page 88 and 89:
Page 90 and 91:
Section 4HIV status. Disclosing one
Page 92 and 93:
Section 53. After, provide the foll
Page 94 and 95:
Section 5Some examples could includ
Page 96 and 97:
Section 57. Tell the group that we
Page 98 and 99:
Section 5and have them draw or writ
Page 100 and 101:
Section 5Characteristics of a Poor
Page 102 and 103:
Section 52. Ask for six volunteers.
Page 104 and 105:
3SECTION 5Section 5COUNSELING ON AD
Page 106 and 107:
Section 55. Begin a discussion with
Page 109 and 110:
SCHEDULE FOR DAY 4Day Four : Care a
Page 111 and 112:
Section 53. They should write their
Page 113 and 114:
Section 54. Adherence to treatment
Page 115 and 116:
Section 5III.Issues specific to men
Page 117 and 118:
Section 54SECTION 5COUNSELING ON AD
Page 119 and 120:
Section 64SECTION 6CARE AND SUPPORT
Page 121 and 122:
Section 64SECTION 6CARE AND SUPPORT
Page 123 and 124:
Section 6(List these tasks on the f
Page 125 and 126:
Section 73. Assign each group one o
Page 127 and 128:
Section 73. Review Handout 7.2 : He
Page 129 and 130:
Section 82. Participants will now d
Page 131 and 132:
Section 84SECTION 8SERVICES FOR PLH
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Section 94SECTION 9SKILLS FOR PEER
Page 139 and 140:
Section 97. After all groups are fi
Page 141 and 142:
Section 9• A good relationship wi
Page 143 and 144:
Section 9bottle with the label so t
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Section 10110CLOSINGSESSION 10.1 :
Page 151 and 152:
Section 104 SECTION 10CLOSINGSESSIO
Page 153 and 154:
Section 104 SECTION 10CLOSINGSESSIO
Page 155 and 156:
Section 10As you go around the circ
Page 157 and 158:
12. Number of people living with HI
Page 159 and 160:
13. HIV cannot be transmitted by :
Page 161 and 162:
150Notes
show all

Final Facilitator Guide - EngenderHealth

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?